Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

COPE logo
ISSN: 1177-8881

Journal Articles:

- 5,669 records -

Discharge Readiness After Propofol with or without Esketamine for Flexible Bronchoscopy: A Randomized Non-Inferiority Trial

Zhang X, Chen L, Chen Z, Yang J, Zheng T, Lin W, Guan J, Yao Y

Drug Design, Development and Therapy 2026, 20:612153

Published Date: 22 June 2026

Population Pharmacokinetics and Dose Optimization of Vancomycin in Adult Cancer Patients

Gao J, Gao X, Xu Y, Feng Z, Wang P, Gong W, Wang M

Drug Design, Development and Therapy 2026, 20:608206

Published Date: 20 June 2026

Artificial Intelligence in Selected Domains of Drug Discovery: A Critical Narrative Review

Bin Abdulqader MI, Alsaqabi AA, Mohammed AE, Alghamdi SS

Drug Design, Development and Therapy 2026, 20:607228

Published Date: 19 June 2026

In-vivo Antioxidant Effects of Emodin on Ischemia-Reperfusion Injury of Rat’s Skeletal Muscle

Yiğit D, Oktar GL, Demirtaş H, Özer A, Küçük A, Yığman Z, Tekin E, Arslan M

Drug Design, Development and Therapy 2026, 20:618630

Published Date: 19 June 2026

Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring

Cheng F, Wang F, Cui Z, Li Q, Liu X, Li W

Drug Design, Development and Therapy 2026, 20:612207

Published Date: 18 June 2026

The Pan-Inhibitor of Aurora Kinases Danusertib Induces Apoptosis and Autophagy and Suppresses Epithelial-to-Mesenchymal Transition in Human Breast Cancer Cells [Retraction]

Li J, Yang Y, Liu Q, Zhou Z, Pan S, He Z, Zhang X, Yang T, Pan S, Duan W, He S, Chen X, Qiu J, Zhou S

Drug Design, Development and Therapy 2026, 20:633634

Published Date: 18 June 2026

Plumbagin Induces Cell Cycle Arrest and Autophagy and Suppresses Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR-Mediated Pathway in Human Pancreatic Cancer Cells [Retraction]

Wang F, Wang Q, Zhou Z, Yu S, Pan S, He Z, Zhang X, Wang D, Yang Y, Yang T, Sun T, Li M, Qiu J, Zhou S

Drug Design, Development and Therapy 2026, 20:633642

Published Date: 18 June 2026

Nanocarrier-Mediated Delivery Systems of Phytochemicals to Enhance and Accelerate Diabetic Wound Healing Processes

Wahyuningsih ES, Muhaimin M, Chaerunisaa AY, Khairinisa MA

Drug Design, Development and Therapy 2026, 20:607020

Published Date: 18 June 2026

Neurohormonal-Immune Dysregulation in Rosacea: Emerging Perspectives from the Skin-Gut-Brain Axis

Shi L, Li S, Yao X, Zhang Z, Dong Q, Zhang H, Wang X, Bai J, Han H, Fu X, Zheng K, Liang L

Drug Design, Development and Therapy 2026, 20:608151

Published Date: 16 June 2026

Optimizing Colistin Sulfate Dosing in Severe Infections: A Population Pharmacokinetic Model-Guided Approach

Ma Y, Wang Y, Wu X, Wang J, Pang Y, Jia Y, Yang X, Gu J

Drug Design, Development and Therapy 2026, 20:600942

Published Date: 15 June 2026

Effect of End-Stage Kidney Disease Factor on the Sedative Effects of Ciprofol

Sun D, Han M, Huang X, Lu D, Zhu B, Zhou D, Hua M, Kang F, Li J

Drug Design, Development and Therapy 2026, 20:601965

Published Date: 10 June 2026

Age-Stratified ED95 of Remimazolam Tosilate for Moderate Sedation in Pediatric Patients: A Biased Coin Design Study

Zhu B, Meng W, Pan K, Peng L, Chen X, Wang S, Yang C

Drug Design, Development and Therapy 2026, 20:613464

Published Date: 8 June 2026

Oliceridine in the Prevention of Catheter-Related Bladder Discomfort: A Single-Center, Randomized, Double-Blind, Prospective Trial

Jiang RJ, Gao S, Yang Z, Bin XY, Cheng L, Liu SX

Drug Design, Development and Therapy 2026, 20:605184

Published Date: 8 June 2026

More articles